Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)

NCT00791921 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: CDP870
DRUG: Placebo of CDP870

Sponsor

Otsuka Pharmaceutical Co., Ltd.

Collaborators

[object Object]